Abraham Ceesay

CEO · Rapport Therapeutics, Inc.

Rank #3,029 SEC EDGAR (United States) ↗ Files from United States

Details

Officer and board memberPharmaceuticals & BiotechnologyRAPPSEC CIK 0001722140

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$30.7M
1-day change
▼ 3.90%
Positions on file
3
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 3 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$9.9M – $32.6M2026-09-04

Insider activity Jun 12, 2024 – Feb 18, 2026

Abraham Ceesay is recorded in filings to the U.S. SEC via EDGAR as officer and board member, and reported 28 transactions between Jun 12, 2024 and Feb 18, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$3.56M
25 sales on file priced rows only
All reported transactions
28
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Abraham Ceesay sold 18,921 Rapport Therapeutics, Inc. (RAPP) shares for $937,914 on Aug 25, 2026

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Abraham Ceesay sold 18,921 Rapport Therapeutics, Inc. (RAPP) shares for $937,914 on Aug 25, 2026
Date Insider Transaction Shares Price Value Filing
Aug 25, 2026 Abraham Ceesay S Open-market sale 18,921 held after: 467,187 $49.57 $937,914 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Abraham Ceesay sold 19,500 Rapport Therapeutics, Inc. (RAPP) shares for $936,780 on Aug 11, 2026

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Abraham Ceesay sold 19,500 Rapport Therapeutics, Inc. (RAPP) shares for $936,780 on Aug 11, 2026
Date Insider Transaction Shares Price Value Filing
Aug 11, 2026 Abraham Ceesay S Open-market sale 19,500 held after: 491,902 $48.04 $936,780 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 11 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 43 on file in total. See the full history on EDGAR ↗

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Rapport Therapeutics, Inc. RAPP S Open-market sale × 2 8,210 shares $374.5K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,069 $46.01 $49.2K SEC filing ↗
    7,141 $45.56 $325.3K SEC filing ↗
  2. Rapport Therapeutics, Inc. RAPP S Open-market sale 18,921 shares $937.9K at $49.57 SEC filing ↗
  3. Rapport Therapeutics, Inc. RAPP S Open-market sale × 3 28,958 shares $1.39M
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    5,794 $48.62 $281.7K SEC filing ↗
    19,500 $48.04 $936.8K SEC filing ↗
    3,664 $46.90 $171.8K SEC filing ↗
  4. Rapport Therapeutics, Inc. RAPP S Open-market sale × 2 22,541 shares $1.04M
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    8,370 $46.75 $391.3K SEC filing ↗
    14,171 $45.97 $651.4K SEC filing ↗
  5. Rapport Therapeutics, Inc. RAPP S Open-market sale × 2 2,210 shares $93.1K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    7 $42.74 $299 SEC filing ↗
    2,203 $42.11 $92.8K SEC filing ↗
  6. Rapport Therapeutics, Inc. RAPP S Open-market sale × 2 8,210 shares $328.4K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    2,729 $40.57 $110.7K SEC filing ↗
    5,481 $39.72 $217.7K SEC filing ↗
  7. Rapport Therapeutics, Inc. RAPP S Open-market sale × 2 8,220 shares $327.4K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    876 $40.34 $35.3K SEC filing ↗
    7,344 $39.77 $292.1K SEC filing ↗
  8. CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL A Grant or awardnot a buy/sell decision 1,438 shares $255.4K at $177.62 SEC filing ↗
  9. Rapport Therapeutics, Inc. RAPP S Open-market sale × 4 10,916 shares $320.4K
    The 4 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    2,281 $29.80 $68.0K SEC filing ↗
    2,983 $29.04 $86.6K SEC filing ↗
    2,100 $29.80 $62.6K SEC filing ↗
    3,552 $29.05 $103.2K SEC filing ↗
  10. Rapport Therapeutics, Inc. RAPP S Open-market sale × 2 10,916 shares $285.1K
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    5,833 $26.12 $152.4K SEC filing ↗
    5,083 $26.11 $132.7K SEC filing ↗
  11. Rapport Therapeutics, Inc. RAPP S Open-market sale × 4 7,609 shares $223.7K
    The 4 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    2,147 $28.84 $61.9K SEC filing ↗
    600 $31.04 $18.6K SEC filing ↗
    2,441 $28.84 $70.4K SEC filing ↗
    2,421 $30.04 $72.7K SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
Rapport Therapeutics, Inc. RAPP Common Stock 658,705 $45.77 $30.1M 4 EDGAR ↗
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL Common Stock 946 $288.50 $272.9K 4 EDGAR ↗
Pacira BioSciences, Inc. PCRX Common Stock 9,039 $26.35 $238.2K 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Abraham Ceesay reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.